Alison Bauerlein, the Chief Operating Officer of $SGHT, sold 12,728 shares of the company on 05-18-2026 for an estimated $65,167. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.8% of their shares of this class of stock. Following this trade, they now own 688,893 shares of this class of $SGHT stock.
$SGHT Insider Trading Activity
$SGHT insiders have traded $SGHT stock on the open market 26 times in the past 6 months. Of those trades, 1 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $SGHT stock by insiders over the last 6 months:
- JEREMY B. HAYDEN (Chief Legal Officer) has made 0 purchases and 5 sales selling 76,089 shares for an estimated $539,741.
- PAUL BADAWI (President and CEO) has made 0 purchases and 4 sales selling 88,832 shares for an estimated $533,421.
- ALISON BAUERLEIN (Chief Operating Officer) has made 0 purchases and 4 sales selling 59,145 shares for an estimated $312,575.
- DAVID BADAWI (Chief Technology Officer) has made 0 purchases and 5 sales selling 22,664 shares for an estimated $133,587.
- STAFFAN ENCRANTZ purchased 13,958 shares for an estimated $115,963
- JAMES RODBERG (Chief Financial Officer) has made 0 purchases and 5 sales selling 17,364 shares for an estimated $102,651.
- BRENTON TAYLOR (EVP, Operations & R&D) has made 0 purchases and 2 sales selling 3,488 shares for an estimated $15,245.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SGHT Hedge Fund Activity
We have seen 62 institutional investors add shares of $SGHT stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PATHSTONE HOLDINGS, LLC added 1,678,980 shares (+233.7%) to their portfolio in Q1 2026, for an estimated $6,329,754
- PROSIGHT MANAGEMENT, LP removed 439,941 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,488,732
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC removed 425,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,602,250
- QUBE RESEARCH & TECHNOLOGIES LTD added 422,822 shares (+566.1%) to their portfolio in Q1 2026, for an estimated $1,594,038
- INVESCO LTD. added 352,005 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,791,399
- JACOBS LEVY EQUITY MANAGEMENT, INC added 313,866 shares (+2234.6%) to their portfolio in Q1 2026, for an estimated $1,183,274
- LONG FOCUS CAPITAL MANAGEMENT, LLC added 301,619 shares (+9.2%) to their portfolio in Q1 2026, for an estimated $1,137,103
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SGHT Revenue
$SGHT had revenues of $19.7M in Q1 2026. This is an increase of 12.51% from the same period in the prior year.
You can track SGHT financials on Quiver Quantitative's SGHT stock page.
You can access data on SGHT stock through the Quiver Quantitative API.
$SGHT Analyst Ratings
Wall Street analysts have issued reports on $SGHT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 12/10/2025
To track analyst ratings and price targets for $SGHT, check out Quiver Quantitative's $SGHT forecast page.
$SGHT Price Targets
Multiple analysts have issued price targets for $SGHT recently. We have seen 6 analysts offer price targets for $SGHT in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- Danielle Antalffy from UBS set a target price of $11.0 on 03/06/2026
- Joanne Wuensch from Citigroup set a target price of $6.5 on 03/06/2026
- Thomas Stephan from Stifel set a target price of $8.0 on 03/02/2026
- Adam Maeder from Piper Sandler set a target price of $9.0 on 01/05/2026
- Frank Takkinen from Lake Street set a target price of $12.0 on 12/10/2025
- Cecilia Furlong from Morgan Stanley set a target price of $8.0 on 12/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
